$LTUM Balance Sheet | Understand Stock

$LTUM

$0.05 -$0.00 (0.3%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
CURRENT ASSETS
Cash
Cash
Marketable securities
Deposits
Prepaid expenses
Total Current Assets
Equipment, net of accumulated depreciation
TOTAL ASSETS
CURRENT LIABILITIES
Accounts payable and accrued liabilities
Accounts payable and accrued liabilities - related party
Allowance for optioned properties
Accounts payable and accrued liabilities - related party
Allowance for optioned properties
TOTAL CURRENT LIABILITIES
TOTAL LIABILITIES
Commitments and contingencies
STOCKHOLDERS' EQUITY
Common stock, 3,000,000,000 shares authorized, par value $0.001; 117,892,441 and 117,892,441 common shares outstanding, respectively
Additional paid in capital
Additional paid in capital - options
Additional paid in capital - warrants
Accumulated deficit
TOTAL STOCKHOLDERS' EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

Comments